Writing for Law360, Partner Tim Cook published an analysis overviewing the safe harbor provision that is the Hatch-Waxman Act, how it may apply in the emerging field of cell and gene therapies, and how companies can continue to work in this space while these questions are resolved.
We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.
